Evidence map›Paper›PMID 41340780›Full record

ArticleRadiology case reports2026

Giant trigeminal schwannoma with cavernous sinus and brainstem involvement: Multimodal imaging and multidisciplinary surgical management.

Saad Bouchlarhem, Mohammed Amine Rabhi, Achraf Amine Sbai, Drissia Benfadil, Azeddine Lachkar

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saad BouchlarhemFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Mohammed Amine RabhiFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Achraf Amine SbaiFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Drissia BenfadilFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Azeddine LachkarFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trigeminal schwannomas (TS) are rare, benign tumors originating from Schwann cells of the trigeminal nerve. These tumors typically present with progressive facial hypoesthesia, and less commonly with trigeminal neuralgia or brainstem compression in advanced cases. The case presented here involves a 48-year-old female with a medical history of well-controlled arterial hypertension, who developed progressive right-sided facial numbness over an 8-month period. Magnetic resonance imaging (MRI) with gadolinium contrast revealed a right-sided trigeminal schwannoma extending into the cavernous sinus and posterior fossa, measuring 39 × 24 mm. The tumor exhibited hypointense signal on T1-weighted images and marked hyperintensity on T2-weighted sequences, consistent with cystic degeneration. Surgical resection was performed with near-total resection, and the postoperative course was uneventful, although facial hypoesthesia persisted. This case highlights the importance of early diagnosis, multimodal imaging, and a multidisciplinary approach to managing giant trigeminal schwannomas, particularly those involving the cavernous sinus and brainstem. Key lessons learned include the role of 3D-CISS imaging in guiding surgical approach selection and the need for careful perioperative planning to optimize outcomes and minimize neurological deficits.

Indexed as

Cranial nerve V tumorFacial hypoesthesiaParoxysmal facial painSkull base neoplasmTrigeminal schwannoma

Identifiers

PMID41340780
PMCPMC12670899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.